Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model

References

• HeintzAPMOdicinoFMaisonneuvePBellerUBenedetJLCreasmanWTInternational Federation of Gynecology and Obstetrics 25th Annual Report. Carcinoma of the OvaryInt J Gyn Obst200383135137
   PubMed Web of Science ®Google Scholar
• American Cancer SocietyCancer facts and figures2007 Cited on Nov 6, 2008. Available from http://www.cancer.org
   Google Scholar
• McGuireWPHoskinsWJBradyMFCyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancerN Engl J Med1996334167494563
   PubMed Web of Science ®Google Scholar
• McGuireWPOzolsRFChemotherapy of advanced ovarian cancerSemin Oncol1998253403489633846
   PubMed Web of Science ®Google Scholar
• PiccartMJBertelsenKJamesKRandomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year resultsJ Natl Cancer Inst20009269970810793106
   PubMed Web of Science ®Google Scholar
• LeitaoMMJrHummerADizonDSPlatinum re-treatment of platinum-resistant ovarian cancer after non-platinum therapyGynecol Oncol20039112312914529671
   PubMed Web of Science ®Google Scholar
• LamberthEGregoryWMNelstropAERustinGJLong-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal populationInt J Gynecol Cancer20041477277815361183
   PubMed Web of Science ®Google Scholar
• OttIGustRNon platinum metal complexes as anti-cancer drugsArch Pharm2007340117126
   PubMed Web of Science ®Google Scholar
• AndrewsPHowellSCellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistanceCancer Cell199023543
   PubMed Web of Science ®Google Scholar
• HorowitzNHuaJGibbRMutchDHerzogTThe role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro modelGynecol Oncol200494677315262121
   PubMed Web of Science ®Google Scholar
• Köpf-MaierPComplexes of metals other than platinum as antitumour agentsEur J Clin Pharmacol1994471167988618
   PubMed Web of Science ®Google Scholar
• HuangRWallquistACovellDGAnticancer metal compounds in NCI-s tumor-screening database: putative mode of actionBiochem Pharmacol2005691009103915763539
   PubMed Web of Science ®Google Scholar
• ZhongXWeihLiuWSWangDQWangXThe crystal structures of copper(II), manganese(II), and nickel(II) complexes of a (Z)-2-hydroxy-N′-(2-oxoindolin-3-ylidene) benzohydrazide-potential antitumor agentsBioorg Med Chem Lett2007173774377717466518
   PubMed Web of Science ®Google Scholar
• LangeTSKimKKSinghRKStronginRMMcCourtCKBrardLIron(III)-salophene: An metallo-organic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cellsPLOS One20083e2303110
   Google Scholar
• BiCFanYSunGZhengGZhangGSynthesis and characterization of Ln(III) complexes with N, N′-p-phenylenebis-(o-vanillylideneimine)Syn React Inorg Met200131219225
   Google Scholar
• RoseGSToccoLMGrangerGADevelopment and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 ratAm J Obstet Gynecol19961755935998828419
   PubMed Web of Science ®Google Scholar
• LangeTSSinghRKKimKKAnti-proliferative and pro-apoptotic Properties of 3-Bromoacetoxy Calcidiol (B3CD) in high-Risk NeuroblastomaChem Biol Drug Design200770302310
   PubMed Web of Science ®Google Scholar
• MalichGMarkovicBWinderCThe sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell linesToxicology19971241791929482120
   PubMed Web of Science ®Google Scholar
• HayakawaJOhmichiMKurachiHInhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell lineJ Biol Chem1999274316483165410531373
   PubMed Web of Science ®Google Scholar
• BurrowsCJRokitaSERecognition of guanine structure in nucleic acids by nickel complexesAcc Chem Res199427295301
   Web of Science ®Google Scholar
• MandalSSVarshneyUBhattacharyaSRole of the central metal ion and ligand charge in the DNA binding and modification by metallosalen complexesBioconjugate Chem19978798812
   PubMed Web of Science ®Google Scholar
• RoutierSCotelleNCatteauJPSalen-anthraquinone conjugates. Synthesis, DNA-binding and cleaving properties, effects on topoisomerases and cytotoxicityBioorg Med Chem19964118511968879539
   PubMed Web of Science ®Google Scholar
• RoutierSBernierJLCatteauJPSynthesis, DNA binding, and cleaving properties of an ellipticine-salen. copper conjugateBioconjugate Chem19978789792
   PubMed Web of Science ®Google Scholar
• WoldemariamGAMandalSSIron(III)-salen damages DNA and induces apoptosis inhuman cells via mitochondrial pathwayJ Inorg Biochem200810274074718180039
   PubMed Web of Science ®Google Scholar
• RoutierS VezinhLamourEBernierJLCatteauJPBaillyCDNA-cleavage by hydroxy-salicylidene-ethylendiamine-iron complexesNucl Acid Res19992741604166
   PubMed Web of Science ®Google Scholar
• ShapiroGIHarperJWAnticancer drug targets: cell-cycle and checkpoint controlJ Clin Invest19991041645165310606615
   PubMed Web of Science ®Google Scholar
• GladdenABDiehlJACell-cycle progression without cyclin E/CDK2: breaking down the walls of dogmaCancer Cell2003416016214522248
   PubMed Web of Science ®Google Scholar
• MazumderSDuPreeELAlmasanAA dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapyCurr Cancer Drug Targets20044657514965268
   PubMed Web of Science ®Google Scholar
• KimREmiMTanabeKMurakamiSUchidaYArihiroKRegulation and interplay of apoptotic and non-apoptotic cell deathJ Pathol200620831932616261658
   PubMed Web of Science ®Google Scholar
• PetitPXLecoeurHZornEDauguetCMignotteBGougeonMLAlterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosisJ Cell Biol19951301571677790370
   PubMed Web of Science ®Google Scholar